The Diagnostic Value of the Systemic Immune-Inflammation Index for Venous Thromboembolism in Lung Cancer Patients: A Retrospective Study

<div>The nomogram for predicting VTE risk in lung cancer patients based on the systemic immune-inflammatory index (SII). Different scores were obtained for each variable, after which the total scores of the 6 items were assessed for the corresponding VTE predicted risk.</div>

Mediators of Inflammation

fig2

Figure 2

Figure 2: The Diagnostic Value of the Systemic Immune-Inflammation Index for Venous Thromboembolism in Lung Cancer Patients: A Retrospective Study 